Lactoferrin (Lf), an iron-binding glycoprotein expressed in most biological fluids, represents a major component of the mammalian innate immune system. Lf’s multiple activities rely not only on its capacity to bind iron, but also to interact with molecular and cellular components of both host and pathogens. Lf can bind and sequester lipopolysaccharide (LPS), thus preventing pro-inflammatory pathway activation, sepsis and tissue damage. However, Lf-bound LPS may retain the capacity to induce cell activation via Toll-like receptor 4-dependent and -independent mechanisms. This review discusses the complex interplay between Lf and LPS and its relevance in the regulation of the immune response.
References
[1]
Beutler, B.; Rietschel, E.T. Innate immune sensing and its roots: The story of endotoxin. Nat. Rev. Immunol.？2003, 3, 169–176. 12563300
[2]
Westphal, O.; Luderitz, O.; Rietschel, E.T.; Galanos, C. Bacterial lipopolysaccharide and its lipid A component: Some historical and some current aspects. Biochem. Soc. Trans.？1981, 9, 191–195. 7274542
Schumann, R.R.; Leong, S.R.; Flaggs, G.W.; Gray, P.W.; Wright, S.D.; Mathison, J.C.; Tobias, P.S.; Ulevitch, R.J. Structure and function of lipopolysaccharide binding protein. Science？1990, 249, 1429–1431. 2402637
[7]
Wright, S.D.; Ramos, R.A.; Tobias, P.S.; Ulevitch, R.J.; Mathison, J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science？1990, 249, 1431–1433. 1698311
[8]
Pugin, J.; Ulevitch, R.J.; Tobias, P.S. A critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation. J. Exp. Med.？1993, 178, 2193–2200. 7504060
[9]
Wright, S.D. CD14 and innate recognition of bacteria. J. Immunol.？1995, 155, 6–8. 7541427
[10]
Pugin, J.; Schurer-Maly, C.C.; Leturcq, D.; Moriarty, A.; Ulevitch, R.J.; Tobias, P.S. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA？1993, 90, 2744–2748, doi:10.1073/pnas.90.7.2744. 7681988
[11]
Heumann, D.; Roger, T. Initial responses to endotoxins and Gram-negative bacteria. Clin. Chim. Acta？2002, 323, 59–72. 12135807
[12]
Shimazu, R.; Akashi, S.; Ogata, H.; Nagai, Y.; Fukudome, K.; Miyake, K.; Kimoto, M. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med.？1999, 189, 1777–1782, doi:10.1084/jem.189.11.1777. 10359581
[13]
Munford, R.S. Detoxifying endotoxin: Time, place and person. J. Endotoxin. Res.？2005, 11, 69–84. 15949133
[14]
Legrand, D.; Pierce, A.; Elass, E.; Carpentier, M.; Mariller, C.; Mazurier, J. Lactoferrin structure and functions. Adv. Exp. Med. Biol.？2008, 606, 163–194. 18183929
[15]
Valenti, P.; Antonini, G. Lactoferrin: An important host defence against microbial and viral attack. Cell Mol. Life Sci.？2005, 62, 2576–2587. 16261253
[16]
Appelmelk, B.J.; An, Y.Q.; Geerts, M.; Thijs, B.G.; de Boer, H.A.; MacLaren, D. M.; de Graaff, J.; Nuijens, J.H. Lactoferrin is a lipid A-binding protein. Infect. Immun.？1994, 62, 2628–2632. 8188389
[17]
Baveye, S.; Elass, E.; Fernig, D.G.; Blanquart, C.; Mazurier, J.; Legrand, D. Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex. Infect. Immun.？2000, 68, 6519–6525, doi:10.1128/IAI.68.12.6519-6525.2000. 11083760
[18]
Britigan, B.E.; Lewis, T.S.; Waldschmidt, M.; McCormick, M.L.; Krieg, A.M. Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells. J. Immunol.？2001, 167, 2921–2928. 11509640
[19]
Legrand, D.; Elass, E.; Carpentier, M.; Mazurier, J. Interactions of lactoferrin with cells involved in immune function. Biochem. Cell Biol.？2006, 84, 282–290. 16936798
[20]
Puddu, P.; Valenti, P.; Gessani, S. Immunomodulatory effects of lactoferrin on antigen presenting cells. Biochimie？2009, 91, 11–18. 18539153
[21]
Baker, E.N.; Baker, H.M. Molecular structure, binding properties and dynamics of lactoferrin. Cell Mol. Life Sci.？2005, 62, 2531–2539, doi:10.1007/s00018-005-5368-9. 16261257
[22]
Baker, E.N.; Baker, H.M. A structural framework for understanding the multifunctional character of lactoferrin. Biochimie？2009, 91, 3–10. 18541155
[23]
Bellamy, W.; Takase, M.; Yamauchi, K.; Wakabayashi, H.; Kawase, K.; Tomita, M. Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta？1992, 1121, 130–136. 1599934
[24]
Senkovich, O.; Cook, W.J.; Mirza, S.; Hollingshead, S.K.; Protasevich, II; Briles, D.E.; Chattopadhyay, D. Structure of a complex of human lactoferrin N-lobe with pneumococcal surface protein a provides insight into microbial defense mechanism. J. Mol. Biol.？2007, 370, 701–713, doi:10.1016/j.jmb.2007.04.075. 17543335
[25]
Sabatucci, A.; Vachette, P.; Vasilyev, V.B.; Beltramini, M.; Sokolov, A.; Pulina, M.; Salvato, B.; Angelucci, C.B.; Maccarrone, M.; Cozzani, I.; Dainese, E. Structural characterization of the ceruloplasmin: Lactoferrin complex in solution. J. Mol. Biol.？2007, 371, 1038–1046. 17597152
[26]
Mann, D.M.; Romm, E.; Migliorini, M. Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin. J. Biol. Chem.？1994, 269, 23661–23667. 8089135
[27]
van Berkel, P.H.; Geerts, M.E.; van Veen, H.A.; Mericskay, M.; de Boer, H.A.; Nuijens, J.H. N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. Biochem. J.？1997, 328, 145–151. 9359845
[28]
Elass-Rochard, E.; Roseanu, A.; Legrand, D.; Trif, M.; Salmon, V.; Motas, C.; Montreuil, J.; Spik, G. Lactoferrin-lipopolysaccharide interaction: Involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. Biochem. J.？1995, 312, 839–845. 8554529
[29]
Legrand, D.; van Berkel, P.H.; Salmon, V.; van Veen, H.A.; Slomianny, M.C.; Nuijens, J.H.; Spik, G. The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells. Biochem. J.？1997, 327, 841–846. 9581564
[30]
Wu, H.F.; Monroe, D.M.; Church, F.C. Characterization of the glycosaminoglycan-binding region of lactoferrin. Arch. Biochem. Biophys.？1995, 317, 85–92. 7872808
[31]
Ellison, R.T., 3rd; Giehl, T.J. Killing of gram-negative bacteria by lactoferrin and lysozyme. J. Clin. Invest.？1991, 88, 1080–1091, doi:10.1172/JCI115407. 1918365
[32]
Rossi, P.; Giansanti, F.; Boffi, A.; Ajello, M.; Valenti, P.; Chiancone, E.; Antonini, G. Ca2+ binding to bovine lactoferrin enhances protein stability and influences the release of bacterial lipopolysaccharide. Biochem. Cell Biol.？2002, 80, 41–48. 11908642
[33]
Haridas, M.; Anderson, B.F.; Baker, E.N. Structure of human diferric lactoferrin refined at 2.2 ？ resolution. Acta. Crystallogr. D. Biol. Crystallogr.？1995, 51, 629–646, doi:10.1107/S0907444994013521. 15299793
[34]
Moore, S.A.; Anderson, B.F.; Groom, C.R.; Haridas, M.; Baker, E.N. Three-dimensional structure of diferric bovine lactoferrin at 2.8 ？ resolution. J. Mol. Biol.？1997, 274, 222–236, doi:10.1006/jmbi.1997.1386. 9398529
[35]
Chung, M.C.; Wines, B.D.; Baker, H.; Langley, R.J.; Baker, E.N.; Fraser, J.D. The crystal structure of staphylococcal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition. Mol. Microbiol.？2007, 66, 1342–1355. 18045383
[36]
Choi, B.K.; Actor, J.K.; Rios, S.; d'Anjou, M.; Stadheim, T.A.; Warburton, S.; Giaccone, E.; Cukan, M.; Li, H.; Kull, A.; Sharkey, N.; Gollnick, P.; Kocieba, M.; Artym, J.; Zimecki, M.; Kruzel, M.L.; Wildt, S. Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: Effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune response. Glycoconj. J.？2008, 25, 581–593. 18365311
[37]
Zimecki, M.; Kocieba, M.; Kruzel, M. Immunoregulatory activities of lactoferrin in the delayed type hypersensitivity in mice are mediated by a receptor with affinity to mannose. Immunobiology？2002, 205, 120–131. 11999341
[38]
Groot, F.; Geijtenbeek, T.B.; Sanders, R.W.; Baldwin, C.E.; Sanchez-Hernandez, M.; Floris, R.; van Kooyk, Y.; de Jong, E.C.; Berkhout, B. Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN--gp120 interaction. J. Virol.？2005, 79, 3009–3015. 15709021
[39]
Brandenburg, K.; Jurgens, G.; Muller, M.; Fukuoka, S.; Koch, M.H. Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin. Biol. Chem.？2001, 382, 1215–1225. 11592403
[40]
Brandenburg, K.; Kusumoto, S.; Seydel, U. Conformational studies of synthetic lipid A analogues and partial structures by infrared spectroscopy. Biochim. Biophys. Acta？1997, 1329, 183–201. 9370256
[41]
Schromm, A.B.; Brandenburg, K.; Loppnow, H.; Moran, A.P.; Koch, M.H.; Rietschel, E.T.; Seydel, U. Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur. J. Biochem.？2000, 267, 2008–2013. 10727940
[42]
Mattsby-Baltzer, I.; Roseanu, A.; Motas, C.; Elverfors, J.; Engberg, I.; Hanson, L.A. Lactoferrin or a fragment thereof inhibits the endotoxin-induced interleukin-6 response in human monocytic cells. Pediatr. Res.？1996, 40, 257–262, doi:10.1203/00006450-199608000-00011. 8827774
[43]
Elass-Rochard, E.; Legrand, D.; Salmon, V.; Roseanu, A.; Trif, M.; Tobias, P.S.; Mazurier, J.; Spik, G. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein. Infect. Immun.？1998, 66, 486–491. 9453600
[44]
Baveye, S.; Elass, E.; Mazurier, J.; Legrand, D. Lactoferrin inhibits the binding of lipopolysaccharides to L-selectin and subsequent production of reactive oxygen species by neutrophils. FEBS Lett.？2000, 469, 5–8. 10708745
[45]
Choe, Y.H.; Lee, S.W. Effect of lactoferrin on the production of tumor necrosis factor-alpha and nitric oxide. J. Cell Biochem.？1999, 76, 30–36. 10580998
[46]
Haversen, L.; Ohlsson, B.G.; Hahn-Zoric, M.; Hanson, L.A.; Mattsby-Baltzer, I. Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B. Cell Immunol.？2002, 220, 83–95. 12657243
[47]
Crouch, S.P.; Slater, K.J.; Fletcher, J. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood？1992, 80, 235–240. 1535239
[48]
Andra, J.; Lohner, K.; Blondelle, S.E.; Jerala, R.; Moriyon, I.; Koch, M.H.; Garidel, P.; Brandenburg, K. Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide. Biochem. J.？2005, 385, 135–143. 15344905
[49]
Elass, E.; Masson, M.; Mazurier, J.; Legrand, D. Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells. Infect. Immun.？2002, 70, 1860–1866. 11895948
[50]
Hirotani, Y.; Ikeda, K.; Kato, R.; Myotoku, M.; Umeda, T.; Ijiri, Y.; Tanaka, K. Protective effects of lactoferrin against intestinal mucosal damage induced by lipopolysaccharide in human intestinal Caco-2 cells. Yakugaku Zasshi？2008, 128, 1363–1368. 18758152
[51]
Dawes, M.E.; Tyler, J.W.; Marsh, A.E.; Larson, R.L.; Steevens, B.J.; Lakritz, J. In Vitro effects of lactoferrin on lipopolysaccharide-induced proliferation, gene expression, and prostanoid production by bovine peripheral blood mononuclear cells. Am. J. Vet. Res.？2008, 69, 1164–1170, doi:10.2460/ajvr.69.9.1164. 18764689
[52]
Cohen, M.S.; Mao, J.; Rasmussen, G.T.; Serody, J.S.; Britigan, B.E. Interaction of lactoferrin and lipopolysaccharide (LPS): Effects on the antioxidant property of lactoferrin and the ability of LPS to prime human neutrophils for enhanced superoxide formation. J. Infect. Dis.？1992, 166, 1375–1378. 1331250
[53]
Wang, D.; Pabst, K.M.; Aida, Y.; Pabst, M.J. Lipopolysaccharide-inactivating activity of neutrophils is due to lactoferrin. J. Leukoc. Biol.？1995, 57, 865–874. 7790769
[54]
Zagulski, T.; Lipinski, P.; Zagulska, A.; Broniek, S.; Jarzabek, Z. Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo. Br. J. Exp. Pathol.？1989, 70, 697–704. 2690922
[55]
Zhang, G.H.; Mann, D.M.; Tsai, C.M. Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide. Infect. Immun.？1999, 67, 1353–1358. 10024582
[56]
Kruzel, M.L.; Harari, Y.; Chen, C.Y.; Castro, G.A. Lactoferrin protects gut mucosal integrity during endotoxemia induced by lipopolysaccharide in mice. Inflammation？2000, 24, 33–44. 10704062
[57]
Lee, W.J.; Farmer, J.L.; Hilty, M.; Kim, Y.B. The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets. Infect. Immun.？1998, 66, 1421–1426. 9529062
[58]
Talukder, M.J.; Harada, E. Bovine lactoferrin protects lipopolysaccharide-induced diarrhea modulating nitric oxide and prostaglandin E2 in mice. Can. J. Physiol. Pharmacol.？2007, 85, 200–208. 17487261
[59]
Yajima, M.; Yajima, T.; Kuwata, T. Intraperitoneal injection of lactoferrin ameliorates severe albumin extravasation and neutrophilia in LPS-induced inflammation in neonatal rats. Biomed. Res.？2005, 26, 249–255. 16415506
[60]
Yamaguchi, M.; Matsuura, M.; Kobayashi, K.; Sasaki, H.; Yajima, T.; Kuwata, T. Lactoferrin protects against development of hepatitis caused by sensitization of Kupffer cells by lipopolysaccharide. Clin. Diagn. Lab. Immunol.？2001, 8, 1234–1239. 11687469
[61]
Hayashida, K.; Kaneko, T.; Takeuchi, T.; Shimizu, H.; Ando, K.; Harada, E. Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis. J. Vet. Med. Sci.？2004, 66, 149–154. 15031542
[62]
Mitsuhashi, Y.; Otsuki, K.; Yoda, A.; Shimizu, Y.; Saito, H.; Yanaihara, T. Effect of lactoferrin on lipopolysaccharide (LPS) induced preterm delivery in mice. Acta. Obstet. Gynecol. Scand.？2000, 79, 355–358. 10830761
[63]
Sasaki, Y.; Otsuki, K.; Hasegawa, A.; Sawada, M.; Chiba, H.; Negishi, M.; Nagatsuka, M.; Okai, T. Preventive effect of recombinant human lactoferrin on lipopolysaccharide-induced preterm delivery in mice. Acta. Obstet. Gynecol. Scand.？2004, 83, 1035–1038. 15488117
[64]
Otsuki, K.; Yakuwa, K.; Sawada, M.; Hasegawa, A.; Sasaki, Y.; Mitsukawa, K.; Chiba, H.; Nagatsuka, M.; Saito, H.; Okai, T. Recombinant human lactoferrin has preventive effects on lipopolysaccharide-induced preterm delivery and production of inflammatory cytokines in mice. J. Perinat. Med.？2005, 33, 320–323. 16207117
[65]
Machnicki, M.; Zimecki, M.; Zagulski, T. Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo. Int. J. Exp. Pathol.？1993, 74, 433–439. 8217778
[66]
Kruzel, M.L.; Harari, Y.; Mailman, D.; Actor, J.K.; Zimecki, M. Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice. Clin. Exp. Immunol.？2002, 130, 25–31, doi:10.1046/j.1365-2249.2002.01956.x. 12296849
[67]
Artym, J.; Zimecki, M.; Kruzel, M.L. Effects of lactoferrin on IL-6 production by peritoneal and alveolar cells in cyclophosphamide-treated mice. J. Chemother.？2004, 16, 187–192. 15216955
[68]
Kruzel, M.L.; Actor, J.K.; Radak, Z.; Bacsi, A.; Saavedra-Molina, A.; Boldogh, I. Lactoferrin decreases LPS-induced mitochondrial dysfunction in cultured cells and in animal endotoxemia model. Innate Immun.？2009.
[69]
Na, Y.J.; Han, S.B.; Kang, J.S.; Yoon, Y.D.; Park, S.K.; Kim, H.M.; Yang, K.H.; Joe, C.O. Lactoferrin works as a new LPS-binding protein in inflammatory activation of macrophages. Int. Immunopharmacol.？2004, 4, 1187–1199. 15251114
[70]
Chodaczek, G.; Zimecki, M.; Lukasiewicz, J.; Lugowski, C. A complex of lactoferrin with monophosphoryl lipid A is an efficient adjuvant of the humoral and cellular immune response in mice. Med. Microbiol. Immunol.？2006, 195, 207–216. 16838169
[71]
Miyazawa, K.; Mantel, C.; Lu, L.; Morrison, D.C.; Broxmeyer, H.E. Lactoferrin-lipopolysaccharide interactions Effect on lactoferrin binding to monocyte/macrophage-differentiated HL-60 cells. J. Immunol.？1991, 146, 723–729. 1702815
[72]
Puddu, P.; Carollo, M.G.; Belardelli, F.; Valenti, P.; Gessani, S. Role of endogenous interferon and LPS in the immunomodulatory effects of bovine lactoferrin in murine peritoneal macrophages. J. Leukoc. Biol.？2007, 82, 347–353. 17475783
[73]
Curran, C.S.; Demick, K.P.; Mansfield, J.M. Lactoferrin activates macrophages via TLR4-dependent and -independent signaling pathways. Cell Immunol.？2006, 242, 23–30. 17034774
